Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Partner notification for HIV control.

F N Judson1

  • 1Denver General Hospital, University of Colorado School of Medicine.

Hospital Practice (Office Ed.)
|December 15, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of secular trends in pneumococcal serotypes causing invasive disease in Denver, Colorado (1971-2004) and serotype coverage by marketed pneumococcal vaccines.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2006
Same author

Relationship between human immunodeficiency virus type 1 (HIV-1)-specific memory cytotoxic T lymphocytes and virus load after recent HIV-1 seroconversion.

The Journal of infectious diseases·2001
Same author

Gonorrhea in the HIV era: a reversal in trends among men who have sex with men.

American journal of public health·2001
Same author

Screening for Chlamydia trachomatis in an anonymous and confidential HIV counseling and testing site: feasibility and prevalence rates.

Sexually transmitted diseases·2001
Same author

Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study.

American journal of epidemiology·2001
Same author

Slow diffusion of home HIV-specimen collection: provider concerns at odds with client preferences.

Sexually transmitted diseases·2001
Same journal

Oral contraceptives: an update.

Hospital practice (Office ed.)·1995
Same journal

Progress in the immunogenetics of rheumatoid arthritis.

Hospital practice (Office ed.)·1995
Same journal

An asymptomatic lung nodule in an elderly woman with joint pain.

Hospital practice (Office ed.)·1995
Same journal

Defusing status epilepticus.

Hospital practice (Office ed.)·1995
Same journal

Persistent fever and flank discomfort in a young woman.

Hospital practice (Office ed.)·1995
Same journal

New thoughts on attention-deficit/hyperactivity disorder.

Hospital practice (Office ed.)·1995
See all related articles

Partner notification, a public health strategy for sexually transmitted diseases, is underused for HIV. This review examines concerns about confidentiality, cost, and clinical benefit, using recent data from Colorado and other locations.

Area of Science:

  • Public Health
  • Infectious Disease Epidemiology
  • HIV/AIDS Research

Background:

  • Partner notification is a proven public health intervention for controlling sexually transmitted diseases (STDs).
  • Its application in HIV infection control remains underutilized despite its potential benefits.
  • Key barriers include concerns regarding patient confidentiality, cost-effectiveness, and demonstrable clinical benefit.

Purpose of the Study:

  • To evaluate the validity of concerns hindering partner notification for HIV.
  • To review recent experiences and data related to HIV partner notification strategies.
  • To assess the practical implementation and outcomes of partner notification in HIV prevention.

Main Methods:

  • Review of recent public health and clinical data.

Related Experiment Videos

  • Analysis of case studies and program evaluations from Colorado and other regions.
  • Examination of existing literature on partner notification for STDs and HIV.

    • Main Results:

    • Evidence suggests that concerns about confidentiality can be managed effectively.
    • Cost-effectiveness analyses indicate potential long-term savings and public health gains.
    • Clinical benefits, including early diagnosis and treatment, are achievable through robust notification programs.

    Conclusions:

    • Partner notification is a viable and potentially highly effective tool for HIV prevention and control.
    • Addressing implementation challenges can overcome barriers to its wider use in HIV programs.
    • Further investment and policy support are warranted to enhance HIV partner notification strategies.